Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Paul

Showing results (731-740 of 763) with videos related to

Pageof 77
Sort By:
Schizophrenia Bulletin|February 17, 2021
Obsessive-Compulsive Symptoms and Other Symptoms of the At-risk Mental State for Psychosis: A Network PerspectiveHui Lin Ong, Adela-Maria Isvoranu, Frederike Schirmbeck, et al.
Schizophrenia Research|July 15, 2019
Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy peopleAyedh Alqarni, Todd W Mitchell, Patrick D McGorry, et al.
Schizophrenia Research|March 16, 2020
Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trialSumudu Rasangi Mallawaarachchi, G Paul Amminger, John Farhall, et al.
Schizophrenia Research|October 14, 2019
Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosisAyedh Alqarni, Todd W Mitchell, Patrick D McGorry, et al.
Schizophrenia Bulletin|August 21, 2021
Impact of Comorbid Affective Disorders on Longitudinal Clinical Outcomes in Individuals at Ultra-high Risk for PsychosisFrederike Schirmbeck, Nadine C van der Burg, Matthijs Blankers, et al.
Breast Cancer Research : BCR|May 1, 2019
Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancerNana Weber-Lassalle, Julika Borde, Konstantin Weber-Lassalle, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 26, 2019
Cyclooctatetraene: A Bioactive Cubane Paradigm ComplementHui Xing, Sevan D Houston, Xuejie Chen, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|July 18, 2025
Predicting the First Onset of Suicidal Thoughts and Behaviors in Adolescents Using Multimodal Risk Factors: A Four-Year Longitudinal StudyJosh Nguyen, Dom Dwyer, Yara J Toenders, et al.
American Journal of Human Genetics|December 24, 2025
MSH3 is a genetic modifier of somatic repeat instability in X-linked dystonia parkinsonismAlan Mejia Maza, Madison Hincher, Kevin Correia, et al.
JAMA Psychiatry|October 30, 2024
Slowing Cognitive Decline in Major Depressive Disorder and Mild Cognitive Impairment: A Randomized Clinical TrialTarek K Rajji, Christopher R Bowie, Nathan Herrmann, et al.
Pageof 77

Showing results (731-740 of 763) with videos related to

Sort By:
Pageof 77
Schizophrenia Bulletin|February 17, 2021
Obsessive-Compulsive Symptoms and Other Symptoms of the At-risk Mental State for Psychosis: A Network PerspectiveHui Lin Ong, Adela-Maria Isvoranu, Frederike Schirmbeck, et al.
Schizophrenia Research|July 15, 2019
Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy peopleAyedh Alqarni, Todd W Mitchell, Patrick D McGorry, et al.
Schizophrenia Research|March 16, 2020
Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trialSumudu Rasangi Mallawaarachchi, G Paul Amminger, John Farhall, et al.
Schizophrenia Research|October 14, 2019
Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosisAyedh Alqarni, Todd W Mitchell, Patrick D McGorry, et al.
Schizophrenia Bulletin|August 21, 2021
Impact of Comorbid Affective Disorders on Longitudinal Clinical Outcomes in Individuals at Ultra-high Risk for PsychosisFrederike Schirmbeck, Nadine C van der Burg, Matthijs Blankers, et al.
Breast Cancer Research : BCR|May 1, 2019
Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancerNana Weber-Lassalle, Julika Borde, Konstantin Weber-Lassalle, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 26, 2019
Cyclooctatetraene: A Bioactive Cubane Paradigm ComplementHui Xing, Sevan D Houston, Xuejie Chen, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|July 18, 2025
Predicting the First Onset of Suicidal Thoughts and Behaviors in Adolescents Using Multimodal Risk Factors: A Four-Year Longitudinal StudyJosh Nguyen, Dom Dwyer, Yara J Toenders, et al.
American Journal of Human Genetics|December 24, 2025
MSH3 is a genetic modifier of somatic repeat instability in X-linked dystonia parkinsonismAlan Mejia Maza, Madison Hincher, Kevin Correia, et al.
JAMA Psychiatry|October 30, 2024
Slowing Cognitive Decline in Major Depressive Disorder and Mild Cognitive Impairment: A Randomized Clinical TrialTarek K Rajji, Christopher R Bowie, Nathan Herrmann, et al.
Pageof 77